Sin Tiong Ong

Collaboration Map View Statistics Email Alert RSS Feed

Full Name

Sin Tiong Ong

Variants

Ong, S.T.

Main Affiliation

DUKE-NUS MEDICAL SCHOOL

Faculty

DUKE-NUS MEDICAL SCHOOL

gmsost@nus.edu.sg

Refined By:

Department: CANCER SCIENCE INSTITUTE OF SINGAPORE

Policy: Open

Department: DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)

Type: Article

Date Issued: [2011 TO 2019]

Results 1-4 of 4 (Search time: 0.005 seconds).

Refman EndNote Bibtex RefWorks Excel CSV PDF Send via email

	Issue Date	Title	Author(s)
1	2017	A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer	Soh, S.X; Siddiqui, F.J ; Allen, J.C ; Kim, G.W; Lee, J.C; Yatabe, Y; Soda, M; Mano, H; Soo, R.A ; Chin, T.-M ; Ebi, H; Yano, S; Matsuo, K; Niu, X; Lu, S; Isobe, K; Lee, J.-H; Yang, J.C; Zhao, M; Zhou, C; Lee, J.-K; Lee, S.-H; Lee, J.Y; Ahn, M.-J; Tan, T.J; Tan, D.S ; Tan, E.-H; Ong, S.T ; Lim, W.-T
2	2018	The arginase inhibitor N ? -hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target	Ng K.P. ; Manjeri A. ; Lee L.M. ; Chan Z.E. ; Tan C.Y.; Tan Q.D. ; Majeed A. ; Lee K.L. ; Chuah C. ; Suda T. ; Ong S.T.
3	2014	The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors	Ko T.K. ; Chuah C.T. ; Huang J.W.; Ng K.-P. ; Ong S.T.
4	2017	The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia	Rauzan M. ; Chuah C.T.H. ; Ko T.K. ; Tiong Ong S.